menu search

Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
CAMBRIDGE, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced the pricing of an underwritten public offering of 9,615,384 shares of its common stock at a public offering price of $13.00 per share. The […] The post Fulcrum Therapeutics Announces Pricing of Upsized Public Offering of Common Stock appeared first on ForexTV... Read More
Posted: Jan 18 2023, 04:15
Author Name: forextv
Views: 102888

Search within

Pages Search Results: